Navigation Links
Access MediQuip's Rapid Response To Medtronic Infusion Pump Recall Protects Patients
Date:7/24/2013

Lake Mary, FL (PRWEB) July 24, 2013

Access MediQuip, the nation's first and largest surgical and implant management company, announced today that its industry leading Recall Management Service? (RMS) is helping protect patients nationwide following Class I recalls of a Medtronic infusion pump. Access MediQuip notified its payer partners immediately of the formal recalls of Medtronic's SynchroMed II Implantable Infusion Pump and identified which members were affected.

In June, Medtronic issued four medical device notifications about flaws with the SynchroMed infusion pumps, which are used to deliver pain and other medications. The flaws in the implant are linked to 14 patient deaths over 17 years. The U.S. Food and Drug Administration classified three of the notifications as Class I recalls, indicating the implantable device may cause serious adverse health consequences, including death. The fourth notification was classified as a Class II recall, indicating the possibility of temporary or medically reversible adverse health consequences.

"When there's a surgical device recall such as Medtronic's, speed and precision is essential to protecting patients, especially with Class I and II recalls when a patient's life and safety is at stake," said Prakash Patel, MD, CEO of Access MediQuip. "RMS accelerates the delivery of recall notices to health plans, physicians, facilities, manufacturers, and patients."

When a recall is initiated, RMS leverages Access MediQuip's expansive database of facility, device, and case-related information to identify potentially affected patients through a series of reactive and proactive processes. This capability allows RMS to recognize patients who have already received a defective device and those currently scheduled to receive one. Access MediQuip provides its partners with this HIPAA-compliant corresponding case information, which includes member identification number, name of the facility where the procedure was or is to be performed, physician's name, serial number of the recalled implant, and date of service.

"Thanks to our RMS solution, we are able to provide our partners with the specific information they need concerning any implant recall and support their efforts to ensure patient safety," said Dr. Patel. "There is no better recall management solution on the market, which is why so many payers, facilities, and physicians have made RMS their service of choice."

About Access MediQuip

Access MediQuip is the largest and only company in the country that provides an integrated, comprehensive surgical and implant management solution (SIMS) program. With more than 16 years of experience, Access MediQuip provides payers with analytics to understand their implant spend, manage and control the high costs of implants and surgeries, and improve the quality and safety of surgical procedures, all while maintaining full access and choice of implants for facilities, surgeons and, ultimately, patients. The company was founded in 1997 and is headquartered in Lake Mary, Florida. For more information, please visit http://www.accessmediquip.com.

###

Media Contact:
Lindsey Harris
lharris(at)accessmediquip(dot)com
713-978-4493

Read the full story at http://www.prweb.com/releases/2013/7/prweb10956266.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Image share project gives patients and physicians anytime, anywhere access to medical images
2. Equal access to care helps close survival gap for young African-American cancer patients
3. Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers
4. World Health Assembly endorses new plan to increase global access to vaccines
5. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
6. Researchers offer new approach to track former prisoners access to community HIV care
7. Revised geographic adjustments could improve accuracy of Medicare payments, will not solve access, quality problems
8. Access to clinical trials drives dramatic increases in survival from childhood cancer
9. Disabled Americans Battle for Access to Hotel Pools
10. Expanding Access to Medicaid Would Save Lives: Study
11. The ACCESS-EU study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 2016 , ... An April Gallup survey found rising health care costs to ... Sun Health Senior Living (SHSL) may not share those same worries thanks to ... for the year, while holding the line on increasing their contributions, including premiums, deductibles ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Lung Institute has partnered with ... class starting June 6 at their clinic in downtown Tampa. The class is complimentary ... Lung Institute has created a free downloadable 4 Week Smoking Cessation Guide ...
(Date:5/26/2016)... ... 26, 2016 , ... Eugene Batelli, D.P.M., F.A.C.F.A.S, is celebrating ... accolades and stellar patient reviews, Dr. Batelli continues to be recognized for his ... is a highly trained Podiatric Surgeon who specializes in treating athletes and their ...
(Date:5/26/2016)... ... 2016 , ... A health conscious snack that doesn't sacrifice taste? It's possible! ... an undeniable buzz in the protein product community by offering an alternative to the ... are packed with 11 grams of protein and made from a healthy blend of ...
(Date:5/26/2016)... ... May 26, 2016 , ... May 2016 – Lips may ... to popular cosmetic improvement efforts. Record numbers of clients now ask about lip plumping ... pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , The trend ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met ... bowel cleansing and superiority in , ... of the ascending colon   ... Norgine B.V. today announced new positive data from the phase ... preparation) versus standard 2 litre PEG with ascorbate. The study met ...
(Date:5/24/2016)... May 24, 2016 ARANZ Medical ... the healthcare sector, has been named the Coretex Hi-Tech Emerging ... 2016. Dr Bruce Davey , CEO of ... team.  It,s really good to be recognised for the work ... products are used in 35 countries around the world from ...
(Date:5/24/2016)... N.J. , May 24, 2016 ... oncology drug development company, today provided an update ... dose escalating clinical trial combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  GEN-1 is an IL-12 DNA ...
Breaking Medicine Technology: